STAAR Surgical (NASDAQ:STAA) Holdings Lifted by Defender Capital LLC.

Defender Capital LLC. raised its holdings in STAAR Surgical (NASDAQ:STAA) by 3.5% in the fourth quarter, Holdings Channel reports. The firm owned 701,567 shares of the medical instruments supplier’s stock after purchasing an additional 23,950 shares during the period. STAAR Surgical accounts for 6.3% of Defender Capital LLC.’s investment portfolio, making the stock its 7th largest holding. Defender Capital LLC.’s holdings in STAAR Surgical were worth $17,041,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the stock. State Street Corp increased its holdings in STAAR Surgical by 0.5% in the 3rd quarter. State Street Corp now owns 1,940,567 shares of the medical instruments supplier’s stock worth $72,092,000 after acquiring an additional 10,430 shares during the last quarter. Geode Capital Management LLC raised its stake in STAAR Surgical by 2.7% in the third quarter. Geode Capital Management LLC now owns 1,174,499 shares of the medical instruments supplier’s stock valued at $43,641,000 after purchasing an additional 31,212 shares in the last quarter. Geneva Capital Management LLC raised its position in shares of STAAR Surgical by 0.3% during the 3rd quarter. Geneva Capital Management LLC now owns 695,415 shares of the medical instruments supplier’s stock valued at $25,835,000 after buying an additional 2,241 shares in the last quarter. American Capital Management Inc. lifted its stake in STAAR Surgical by 42.9% during the third quarter. American Capital Management Inc. now owns 512,813 shares of the medical instruments supplier’s stock worth $19,051,000 after purchasing an additional 154,037 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in STAAR Surgical by 25.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 459,655 shares of the medical instruments supplier’s stock worth $21,884,000 after buying an additional 94,422 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Canaccord Genuity Group cut their price target on shares of STAAR Surgical from $31.00 to $28.00 and set a “hold” rating for the company in a research report on Monday, December 9th. Stephens raised shares of STAAR Surgical to a “hold” rating in a research report on Monday, December 2nd. Finally, Needham & Company LLC restated a “hold” rating on shares of STAAR Surgical in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $42.83.

STAAR Surgical Price Performance

Shares of NASDAQ:STAA opened at $24.19 on Thursday. STAAR Surgical has a 1 year low of $21.13 and a 1 year high of $52.68. The stock’s fifty day moving average price is $24.78 and its 200-day moving average price is $30.67. The company has a market cap of $1.19 billion, a P/E ratio of 54.98 and a beta of 0.63.

Insider Activity at STAAR Surgical

In other STAAR Surgical news, major shareholder Broadwood Partners, L.P. purchased 23,000 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were acquired at an average price of $24.33 per share, for a total transaction of $559,590.00. Following the purchase, the insider now directly owns 10,848,631 shares of the company’s stock, valued at $263,947,192.23. The trade was a 0.21 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have purchased a total of 105,876 shares of company stock worth $2,487,168 over the last quarter. Company insiders own 1.00% of the company’s stock.

STAAR Surgical Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.